Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease
Submitted by susan on Mon, 2018-01-08 12:54
The objective of the study was to investigate the kinetics and metabolism of caffeine in serum from patients with Parkinson disease (PD) and controls using liquid chromatography–mass spectrometry.
Main Topic:
Mark Content Private(Internal):
Email Alert:
1-8
Publication Date:
03/01/2018